XML 113 R102.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Reporting - Reconciliation of Adjusted EBITDA (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Jun. 30, 2021
Jun. 30, 2020
Segment Reporting [Abstract]            
Net loss attributable to common shareholders of Evolent Health, Inc. - Basic $ (9,107,000) $ (203,521,000)     $ (18,914,000) $ (282,273,000)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted (9,107,000) (203,521,000)     (18,914,000) (282,273,000)
Interest income 68,000 705,000     191,000 1,475,000
Interest expense (6,274,000) (6,290,000)     (12,611,000) (12,571,000)
(Provision) benefit for income taxes (91,000) 3,904,000     (702,000) 3,634,000
Depreciation and amortization expenses (14,916,000) (15,618,000)     (30,103,000) (31,596,000)
Equity method investment impairment 0 0     0 (47,133,000)
Gain on transfer of membership 0 0     22,969,000 0
Loss on repayment of debt, net 0 0     (19,158,000) 0
Impairment 0 (215,100,000) $ 0 $ (199,800,000) 0 (215,100,000)
Gain from equity method investees 4,879,000 25,143,000     12,662,000 24,731,000
Loss on disposal of assets 0 0     0 (6,447,000)
Change in fair value of contingent consideration and indemnification asset 0 (756,000)     594,000 3,062,000
Other expense, net (18,000) 354,000     (32,000) 284,000
Repositioning costs (663,000) 0     (6,043,000) 0
Stock-based compensation expense (3,653,000) (3,703,000)     (7,359,000) (7,211,000)
Severance costs 0 (30,000)     (52,000) (6,133,000)
Amortization of contract cost assets (196,000) (767,000)     (323,000) (1,207,000)
Strategy and shareholder advisory expenses (1,513,000) 0     (6,513,000) 0
Acquisition costs (76,000) (374,000)     (2,070,000) (683,000)
Gain (loss) from discontinued operations [1] 0 (1,508,000)     1,383,000 (1,773,000)
Adjusted EBITDA $ 13,346,000 $ 10,519,000     $ 28,253,000 $ 14,395,000
[1] Includes $1.9 million gain on disposal of discontinued operations for the six months ended June 30, 2021